NEW YORK (GenomeWeb News) – Biomatrica said today that it has raised $5 million in private financing.
The San Diego-based company said that it would use the funding to strengthen its research initiatives, increase manufacturing capabilities, and improve company infrastructure.
Biomatrica's SampleMatrix technology enables ambient storage of biological samples, including purified DNA, RNA, and proteins, as well as complex systems such as tissue, cell lines, biopsies, and whole blood. The company's products can be used in molecular diagnostics, forensics, biomedical research, and biobanks.
Biomatrica also has received funding from the Defense Advanced Research Project Agency to develop biostability technology under the agency's Diagnostics on Demand program, which aims to deploy next-generation diagnostics technology on a global scale without cold chain requirements.